Mr Mrs Miss Ms Dr Other

Mr
Harry
Gregson

Senior Patent Attorney

London Office

Chemistry

Telephone. +44(0) 113 233 0100
Email. hgregson@hgf.com
Vcard
Linkedin

Experience

Harry is a Chartered UK and European Patent Attorney with extensive experience in drafting and prosecuting patent applications across a range of chemical fields, including pharmaceuticals, agrochemicals, organic synthesis, polymers, and medical devices.

Harry has worked closely with numerous start-ups and SMEs to develop tailored patent strategies aimed at securing robust protection aligned with their commercial objectives. He also regularly handles patent prosecution in jurisdictions outside Europe, including the USA, Japan, Australia, and India, and is therefore well-acquainted with the specific requirements and nuances of their patent systems.

Harry graduated with an MChem in Chemistry with Medicinal Chemistry from Newcastle University in 2018. During his degree, Harry spent a year in industry at a pharmaceutical manufacturing plant, where his work focused primarily on process development.

Specialisms

Industries

Services

Qualifications

Patent Attorney

Chartered (UK)
Europe

MCHEM

Chemistry with Medicinal Chemistry (with Industrial Training Year)

POSTGRADUATE DIPLOMA OR CERTIFICATE

Postgraduate Certificate Intellectual Property

Publications

T 0792/24: Novelty and Inventiveness of Second Medical Use Claims

View publication online

T 1418/22: Acalabrutinib provides guidance on establishing inventiveness of polymorphs at the EPO

View publication online

Exam Success!

View publication online

Related News

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

Agritech Thymes: Unlocking the Soil Microbiome: Driving Agritech Innovation in the UK

The UK offers an ideal platform for harnessing the untapped potential of soil and plant microorganisms. Although much of my professional experience has focused on the human microbiome, I have …

Read article

The Antibody Series #1 | Quality Characteristics (CQAs) in Antibody Claims: When the Test Method Can Remain Outside the Claim

Introduction Therapeutic antibodies are at the heart of innovations in biotechnology and healthcare. With increasing regulatory requirements and quality expectations, critical quality attributes (CQAs) are becoming essential in the drafting …

Read article
Event - 3rd February 2026

HGF Brand & Design Conference 2026

Join us on 3rd February 2026 for HGF’s Brand & Design Conference, the must attend event for in-house legal teams, brand leaders, creatives, and innovators shaping the future of IP. …

Event details

EU Agrees on NGT Plant Regulation: What It Means for Patents and Licensing

The European Parliament and Council have reached a provisional agreement for plants developed using New Genomic Techniques (NGTs) – below we summarise the main points and set out the requirements …

Read article
See all updates

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.

Contact us